TY - JOUR
T1 - Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092)
AU - Valentini, Vincenzo
AU - De Paoli, A
AU - Gambacorta, Maria Antonietta
AU - Mantini, Giovanna
AU - Ratto, Carlo
AU - Vecchio, Fabio Maria
AU - Barbaro, Brunella
AU - Innocente, R
AU - Rossi, Concettina
AU - Boz, G
AU - Barba, Maria Cristina
AU - Frattegiani, Alessandro
AU - Lupattelli, M
AU - Doglietto, Giovanni
PY - 2008
Y1 - 2008
N2 - To report the final data of a Phase I and II study (1839IL/0092) on the combination of an anti-epidermal growth factor receptor drug (gefitinib), infusional 5-fluorouracil, and preoperative radiotherapy in locally advanced, resectable rectal cancer.
AB - To report the final data of a Phase I and II study (1839IL/0092) on the combination of an anti-epidermal growth factor receptor drug (gefitinib), infusional 5-fluorouracil, and preoperative radiotherapy in locally advanced, resectable rectal cancer.
KW - Advanced Rectal Cancer
KW - Preoperative chemioradiotherapy
KW - Advanced Rectal Cancer
KW - Preoperative chemioradiotherapy
UR - http://hdl.handle.net/10807/32968
U2 - 10.1016/j.ijrobp.2008.01.046
DO - 10.1016/j.ijrobp.2008.01.046
M3 - Article
SN - 0360-3016
VL - 72
SP - 644
EP - 649
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
ER -